Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03569202Not ApplicableCompleted

Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye

Role: collaborator

NCT00739713Not ApplicableCompleted

Effects of Sea Buckthorn Oil on Dry Eye

Role: collaborator

NCT01665612Not ApplicableCompleted

The Clinical and Subjective Performance of Three Different MPDS With Silicon Hydrogel Lenses

Role: lead

All 3 trials loaded